IF
MYOV

Ironwood Financial’s Myovant Sciences Ltd. MYOV Stock Holding History

Ironwood Financial’s Portfolio MYOV Stock Details MYOV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-315
Closed -$7K – 589
2021
Q3 		$7K Buy
+315
New +$6.92K ﹤0.01% 412

Other funds holding MYOV

BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
HWAM
Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return

Ironwood Financial's MYOV Position: Q4 2021 in Review

Ironwood Financial sold out of Myovant Sciences Ltd. (MYOV) in Q4 2021, closing a stake of 315 shares — an estimated $7K sold.

Ironwood Financial first reported a position in MYOV in Q3 2021 and held it in 1 quarter. The position peaked at $7K in Q3 2021. 110 funds tracked by Wall St. Rank hold MYOV as of Q4 2021.

  • Ironwood Financial reported no remaining Myovant Sciences Ltd. position as of Q4 2021 after selling out during the quarter.
  • Ironwood Financial sold 315 Myovant Sciences Ltd. shares in Q4 2021, an estimated $7K.
  • Ironwood Financial first reported a position in Myovant Sciences Ltd. in Q3 2021 and held it in 1 quarter.
  • Ironwood Financial's Myovant Sciences Ltd. position peaked at $7K in Q3 2021.
  • 110 funds tracked by Wall St. Rank held Myovant Sciences Ltd. as of Q4 2021.

Based on Ironwood Financial's 13F filing for Q4 2021, filed 28 Jan 2022.